DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Eplivanserin
Eplivanserin
By ANDREA PETERSEN Getty Images for Those Who Have Trouble
204569Orig1s000
(12) United States Patent (10) Patent No.: US 8.598,119 B2 Mates Et Al
Journal of Psychopharmacology
Emerging Anti-Insomnia Drugs: Tackling Sleeplessness and the Quality of Wake Time
WO 2010/065547 Al
(12) Patent Application Publication (10) Pub. No.: US 2015/0290181 A1 Lee Et Al
Method of Treating Sleep Disorders Using Eplivanserin
Novel Implications for Lost Serotonin Transporter Function on Platelet
Serotonin Transporter 5-HTT; SERT; SLC6A4
Eplivanserin | Medchemexpress
5-HT2A Receptors in the Central Nervous System the Receptors
CUSTOMS TARIFF - SCHEDULE 99 - I
Pharmacologyonline 1: 717-725 (2011) Ewsletter Kotade Et Al. 717 I SOM IA
CURRICULUM VITAE Charles M. Morin IDENTIFICATION Address Université Laval École De Psychologie 2325, Rue Des Bibliothèques Q
Stembook 2018.Pdf
PHARMACEUTICAL APPENDIX to the TARIFF SCHEDULE 2 Table 1
Eplivanserin Beats Flurazepam on Next-Day Cognitive Effects
Top View
Chapter # Chapter Title
Role of 5-HT Receptor Antagonists in the Treatment of Insomnia
5-HT2 Receptor Regulation of Mitochondrial Genes: Unexpected Pharmacological Effects of Agonists and Antagonists
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
(12) United States Patent (10) Patent No.: US 9,168.258 B2 Mates Et Al
(12) Patent Application Publication (10) Pub. No.: US 2010/0196286 A1 ARMER Et Al
Customs Tariff - Schedule
(12) United States Patent (10) Patent No.: US 9,526,718 B2 Lee Et Al
Serotonin Receptors – from Molecular Biology to Clinical Applications
Customs Tariff - Schedule Xxi - 1
Sanofi Hoping to Move on from Setbacks Like Eplivanserin
Sedative Antidepressants and Insomnia Antidepressivos Sedativos E Insônia
Eplivanserin Soothes Insomnia Without Next-Morning Effects
Sleep/Wake Activity and Energy Expenditure in Overweight and Obese Obstructive Sleep Apnea Patients : a Pre- and Post-CPAP Comparison
5-HT Receptor Serotonin Receptor; 5-Hydroxytryptamine Receptor
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Insérer Le Titre
Understanding Serotonin 5-HT2A Receptors-Regulated Cellular And
Neurological Disease
Flumazenil N O—N
( 12 ) United States Patent
Method of Treating Sleep Disorders Using Eplivanserin
Insomnia in Elderly Patients: Recommendations for Pharmacological Management
Eplivanserin for Chronic Insomnia Characterised by Difficulties with Sleep Maintenance
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Managing Insomnia
Low Doses of Mirtazapine Or Quetiapine for Transient Insomnia Karsten, Julie; Hagenauw, Loes A.; Kamphuis, Jeanine; Lancel, Marike
•Œdesign and Synthesis of Molecular Probes for The
New Therapeutic Opportunities for 5-HT2 Receptor Ligands
New Approaches Towards Treatment of Insomnia
The Serotonin 5-HT2C Receptor and the Non-Addictive Nature of Classic
022526Orig1s000
Sliwens Withdrawal AR
WO 2010/074753 Al